- AU$20.90m
- AU$16.12m
- AU$3.36m
Brief: Painchek Says Lil Bianchi Appointed Non-Executive Chair
Australia's PainChek surges on fundraising for North America expansion
Australia's PainChek gains most in nearly 7 years on fresh funds for housing facility
Brief: PainChek Says Sabra To Fund Co Across Its 329 Skilled Nursing, Other Facilities In US, Canada
Brief: PainChek Secures First US Customer After FDA Clearance
Brief: Painchek Says FDA De Novo Grant Received For Pain Assessment App
Australia's PainChek Ltd hits over 5-year high after US FDA approves pain app
Brief: Painchek Seeks Trading Halt Pending FDA Clearance
Brief: Painchek Says A$7.5M Placement To Drive International Growth With US FDA Clearance Expected Near Term
Brief: Painchek Seeks Trading Halt Until Capital Raising Announcement
Brief: Painchek Posts Contracted Annual Recurring Revenue Of A$5.4 Million For Quarter
Australia's PainChek drops most in nearly 8 years on FDA approval delay
Brief: Painchek Says Meeting With FDA Agreeing A Revised Timeline For US De Novo Regulatory Clearance
Australia's Painchek hits nearly 20-month high on deal with US co
Brief: Painchek Signs Reseller And Integration Agreement With Eldermark Software LLC
Brief: Painchek To Raise AUD $5.1 Million
Brief: Painchek Seeks Trading Halt Pending Capital Raise Announcement
Australia's PainChek gains on reseller agreement for pain management tech
Brief: PainChek Receives European Patent For Pain Assessment Technology